Related Experiment Videos
[Perspectives on postgenome medicine: Gene therapy for AIDS]
1Division of Clinical Retrovirology and Infectious Diseases, Center for AIDS Research, Kumamoto University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 24, 2001
Summary
Highly active anti-retroviral therapy (HAART) has reduced AIDS deaths, but persistent HIV replication and side effects necessitate new strategies. Gene-based immunotherapy shows promise for controlling HIV, but more research into viral pathogenesis is needed.
Area of Science:
- Immunology
- Virology
- Genetics
Context:
- Highly active anti-retroviral therapy (HAART) has significantly decreased AIDS-related morbidity and mortality.
- Despite HAART's success, persistent HIV replication occurs even with undetectable plasma HIV-RNA.
- Long-term HAART use faces challenges due to side effects and drug resistance.
Purpose:
- To explore the potential of gene-based immunotherapy for controlling HIV replication.
- To investigate the correlation between HIV-specific CD4-T cell response and viral control.
- To highlight the need for further understanding of viral pathogenesis in patients on HAART.
Summary:
- While HAART has improved outcomes, persistent HIV replication and treatment challenges remain.
- HIV-specific CD4-T cell responses are linked to in vivo viral replication control.
- Gene-based immunotherapy is a promising avenue, contingent on deeper insights into HIV pathogenesis.
Impact:
- Advances in understanding HIV pathogenesis under HAART.
- Development of novel gene-based immunotherapies for HIV treatment.
- Improved long-term management strategies for HIV patients.